Insider · CIK 0001873085
Patrik Jeanmonod
Files at CTKB (Cytek Biosciences, Inc.). First filing Oct 25, 2022, latest Dec 27, 2023.
In brief
Patrik Jeanmonod files SEC Form 4 as CFO at CTKB (Cytek Biosciences, Inc.). Since Oct 25, 2022, Patrik Jeanmonod has reported 0 open-market buys worth $0 and 6 open-market sells worth $201k, the latest filed on Dec 27, 2023.
A track record needs three past buys with six months of prices behind them; Patrik Jeanmonod has 0, so none is measured yet.
The newest scored trade: sold $29k of CTKB on Dec 26, 2023, filed Dec 27, 2023, scored 15 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CTKB: Cytek Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Cytek Biosciences, Inc. | $29k 3,000 shares | -3% | +131% from low-30% from high | |
| 10Weak | Cytek Biosciences, Inc. | $21k 3,000 shares | -3% | +70% from low-51% from high | |
| 17Weak | Cytek Biosciences, Inc. | $14k 3,000 shares | -3% | +3% from low-69% from high | |
| 16Weak | Cytek Biosciences, Inc. | $34k 3,500 shares | -4% | +31% from low-44% from high | |
| 24Weak | Cytek Biosciences, Inc. | $50k 3,500 shares | -4% | +93% from low-29% from high | |
| 24Weak | Cytek Biosciences, Inc. | $53k 3,500 shares | -4% | +106% from low-39% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 24, 2023 | CTKB CYTEK BIOSCIENCES INC | 9,000 0.01% of outstanding | $42k | Oct 24, 2023 | $42k |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +4,908 | - | - | 99,377 | Mar 13, 2024 |
| Mar 11, 2024 | CTKB Cytek Biosciences, Inc. | FTax withholding Common Stock | -1,912 | $7.22 | $14k | 97,465 | Mar 13, 2024 |
| Mar 11, 2024 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,908 | $0.00 | $0 | 44,182 | Mar 13, 2024 |
| Feb 20, 2024 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +1,752 | - | - | 95,152 | Feb 22, 2024 |
| Feb 20, 2024 | CTKB Cytek Biosciences, Inc. | FTax withholding Common Stock | -683 | $8.38 | $5,724 | 94,469 | Feb 22, 2024 |
| Feb 20, 2024 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,752 | $0.00 | $0 | 13,442 | Feb 22, 2024 |
| Dec 26, 2023 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $9.50 | $29k | 93,400 | Dec 27, 2023 |
| Nov 24, 2023 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $6.94 | $21k | 96,400 | Nov 27, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +1,752 | - | - | 97,836 | Nov 21, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | FTax withholding Common Stock | -683 | $5.98 | $4,084 | 97,153 | Nov 21, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +3,681 | - | - | 100,834 | Nov 21, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | FTax withholding Common Stock | -1,434 | $5.98 | $8,575 | 99,400 | Nov 21, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,752 | $0.00 | $0 | 15,194 | Nov 21, 2023 |
| Nov 18, 2023 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,681 | $0.00 | $0 | 49,090 | Nov 21, 2023 |
| Oct 24, 2023 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $4.68 | $14k | 96,084 | Oct 25, 2023 |
| Dec 27, 2022 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $9.77 | $34k | 79,632 | Dec 29, 2022 |
| Nov 25, 2022 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $14.30 | $50k | 83,132 | Nov 28, 2022 |
| Nov 18, 2022 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +1,752 | - | - | 87,315 | Nov 22, 2022 |
| Nov 18, 2022 | CTKB Cytek Biosciences, Inc. | FTax withholding Common Stock | -683 | $14.75 | $10k | 86,632 | Nov 22, 2022 |
| Nov 18, 2022 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,752 | $0.00 | $0 | 22,202 | Nov 22, 2022 |
| Oct 24, 2022 | CTKB Cytek Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $15.16 | $53k | 85,563 | Oct 25, 2022 |
Questions about Patrik Jeanmonod
Answered from the filings on this page, as of the latest one.
Is Patrik Jeanmonod buying or selling?
Not in the last 12 months. Patrik Jeanmonod's latest open-market trade on SEC Form 4 was sold $29k of CTKB on Dec 26, 2023.
How did Patrik Jeanmonod's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrik Jeanmonod has 0.
Where does Patrik Jeanmonod file Form 4?
Patrik Jeanmonod has filed Form 4 at CTKB (Cytek Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.